Sana Biotechnology Inc (NAS:SANA)
$ 6.92 -0.06 (-0.86%) Market Cap: 1.53 Bil Enterprise Value: 1.34 Bil PE Ratio: 0 PB Ratio: 4.07 GF Score: 39/100

Sana Biotechnology Inc at Goldman Sachs Healthcare Conference Transcript

Jun 12, 2023 / 05:00PM GMT
Release Date Price: $6.57 (+5.97%)
Salveen Jaswal Richter
Goldman Sachs Group, Inc., Research Division - VP

Good afternoon, everyone. Thank you so much for joining us. We are really pleased to have Steve Harr, President and CEO of Sana. I'm Salveen Richter, biotechnology analyst at Goldman Sachs.

Steve, before we jump into the programs, can you just provide us with a quick overview of your ex vivo hypoimmune and in vivo future platforms and discuss how you're differentiated in this field of cell therapy.

Steven D. Harr
Sana Biotechnology, Inc. - President, CEO & Director

So first of all, thank you for having us. It's great to see you. And thank you for joining us both on the webcast and in this gray and dreary Southern California day. I mean we don't have many of them, so thank you so much for joining us in the room. So I think as you probably know, we'll make a few forward-looking statements, so please do peruse our Q for risk factors and things like that.

So just as a way of background, we believe that one of the most important transformations that will happen in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot